Determination of 8-methoxypsoralen in human plasma, and microdialysates using liquid chromatography-tandem mass spectrometry.
暂无分享,去创建一个
R. Kaufmann | G. Geisslinger | I. Tegeder | M. Podda | H. Schmidt | L. Bräutigam | Maic Seegel | M. Grundmann‐Kollmann | Silke Meier | L. Bräutigam
[1] R. Kaufmann,et al. Time course of 8‐methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8‐methoxypsoralen , 2002, Clinical pharmacology and therapeutics.
[2] T. Zollner,et al. Kinetics and dose–response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations , 2001, The British journal of dermatology.
[3] T. Zollner,et al. Cream PUVA therapy for scleredema adultorum , 2000, The British journal of dermatology.
[4] U. Yeo,et al. Psoralen‐ultraviolet A‐induced erythema: sensitivity correlates with the concentrations of psoralen in suction blister fluid , 2000, The British journal of dermatology.
[5] B. Berne,et al. PUVA and cancer risk: the Swedish follow‐up study , 1999, The British journal of dermatology.
[6] M. Kerscher,et al. Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA‐bath versus PUVA‐cream therapy , 1999, Photodermatology, photoimmunology & photomedicine.
[7] J. Lötsch,et al. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration , 1999, Clinical pharmacology and therapeutics.
[8] M. Kerscher,et al. Plasma levels of 8‐methoxypsoralen following PUVA‐bath photochemotherapy , 1998, Photodermatology, photoimmunology & photomedicine.
[9] G. Plewig,et al. Psoralen bath plus UV-A therapy. Possibilities and limitations. , 1997, Archives of dermatology.
[10] H. Eichler,et al. Diclofenac concentrations in defined tissue layers after topical administration , 1997, Clinical pharmacology and therapeutics.
[11] M. Schmelz,et al. Plasma extravasation and neuropeptide release in human skin as measured by intradermal microdialysis , 1997, Neuroscience Letters.
[12] R. Stern,et al. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. , 1997, The New England journal of medicine.
[13] L. Petersen,et al. Histamine is released in the wheal but not the flare following challenge of human skin in vivo: a microdialysis study , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[14] I. Arranz,et al. Plasma levels of 8‐methoxypsoralen after bath‐PUVA for psoriasis: relationship to disease severity , 1995, The British journal of dermatology.
[15] W. Westerhof,et al. A new psoralen‐containing gel for topical PUVA therapy: development, and treatment results in patients with palmoplantar and plaque‐type psoriasis, and hyperkeratotic eczema , 1995, The British journal of dermatology.
[16] Christopher M. Riley,et al. Microdialysis Sampling for the Investigation of Dermal Drug Transport , 1992, Pharmaceutical Research.
[17] F. Zacchello,et al. Determination of 8-methoxypsoralen in plasma by gas chromatography-mass spectrometry using selected-ion monitoring. , 1992, Journal of chromatography.
[18] U. Ungerstedt,et al. Microdialysis—principles and applications for studies in animals and man , 1991, Journal of internal medicine.
[19] S. E. Thomas,et al. Plasma levels of 8‐methoxypsoralen following oral or bath‐water treatment , 1991, The British journal of dermatology.
[20] C. A. Robinson,et al. Analysis of 8-methoxypsoralen by high-performance liquid chromatography. , 1990, Clinical chemistry.
[21] H. Reinauer,et al. High-performance liquid chromatographic measurement of 8-methoxypsoralen in plasma , 1986 .
[22] D. P. Goldstein,et al. Minimal phototoxic doses and 8-MOP plasma levels in PUVA patients. , 1982, The Journal of investigative dermatology.
[23] M. Schemper,et al. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients. , 1996, Dermatology.
[24] F. Wolff,et al. Clinical Pharmacokinetics of Methoxsalen and Other Psoralens , 1986, Clinical pharmacokinetics.
[25] D. Carter,et al. Plasma levels of 8-methoxypsoralen determined by high-pressure liquid chromatography in psoriatic patients ingesting drug from two manufacturers. , 1980, The Journal of investigative dermatology.
[26] Thomas B. Fitzpatrick,et al. Dermatology in general medicine , 1971 .